Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

How Long Can Omnicare's Dividends Last?

Evaluating the sustainability of dividend payments.

Whether you’re a beginning investor or a near-retiree, the importance of purchasing stocks that pay dividends cannot be overstated. Not only do companies that have quarterly or annual payouts provide you with a steady stream of income, they also have the potential for capital appreciation. Simply put, dividend stocks can give your portfolio what almost no other investment can -- both income and growth.

At The Motley Fool, we’re avid fans of dividends -- and not just because we like that steady stream of cash. Studies have shown that from 1972 to 2006, stocks in the S&P 500 that don’t pay dividends have earned an average annual return of 4.1%; dividend stocks, however, have averaged a whopping 10.1% per year. That is an incredible difference -- one that you’d be crazy to not take advantage of!

But investing in dividends can be dangerous -- companies can cut, slash, or suspend dividends at any time, often without notice. Fortunately, there are several warning signs that may alert you, and these red flags could be the crucial factor in determining whether or not a company is likely to continue paying its dividend. Today, let’s drill beneath the surface and check out Omnicare(NYSE: OCR).

What’s on the surface?Omnicare, which operates in the healthcare services industry, currently pays a dividend of 0.48%. That dividend yield may not seem like much, but considering that over 100 companies in the S&P 500 don’t pay anything at all, it’s nothing to complain about. Plus, don’t forget, dividends typically grow with time, so that 0.48% has the potential to skyrocket over time.

But what’s more important than the dividend itself is Omnicare’s ability to keep that cash rolling. The first thing to look at is the company’s reported dividends versus its reported earnings. If you happen to see dividend payments that are growing faster than earnings per share, it may be an initial signal that something just isn’t right. Check out the graph below for details of the last five years:

Source: Capital IQ, a division of Standard & Poor's.

Clearly, there doesn’t seem to be a huge problem, here. Although earnings have dropped, Omnicare has been able to keep its dividends in check at the same time.

The more secure, the betterOne of the most common metrics that investors use to judge the safety of a dividend is the payout ratio. This number tells you what percentage of net income is paid out to investors in the form of a dividend. Normally, anything above 50% is cause to look a bit further. According to the most recent data, Omnicare’s payout ratio is 30.27%. It’s obvious that, at least on the surface, there aren’t any problems with Omnicare generating enough income to support its 0.48% dividend.

More important than checking out the payout ratio may be simply taking a peek at Omnicare’s cash flow. Free cash flow -- all the cash left over after subtracting out capital expenditures -- is used by firms to make acquisitions, develop new products, and of course, pay dividends! We can use a simple metric called the cash flow coverage ratio, which is cash flow per share divided by dividends per share. Normally, anything above 1.2 should make you feel comfortable; anything less, and you may have a problem on your hands. Omnicare’s coverage ratio is 25.85, -- which is more than enough cash on hand to keep pumping out that 0.48% yield. Barring any unforeseen circumstances, there really shouldn’t be any major problems moving forward.

Either way, it’s always beneficial to compare an investment with its most immediate competitors, so in the chart below, I’ve included the above metrics with those of Omnicare’s closest competitors. In addition, I’ve included the five-year dividend growth rate, which is also a very important indicator. If Omnicare can illustrate that it's grown dividends over the past five years then there’s a good chance that it will continue to put shareholders first in the future. Check out how Omnicare stacks up below against other players in healthcare services:

The Foolish bottom lineOnly you can decide what numbers you’re comfortable with in the end; sometimes a higher yield and a higher reward means additional risk. However, in this situation, Omnicare’s payout ratio seems to be above the peer average, which means if you’re a prudent investor, you may want to look elsewhere for the most secure payment possible. The bottom line, however, is to make sure that with anything -- whether it be a dividend, a share repurchase, or an ordinary earnings report -- you do your own due diligence. Looking at all of the numbers in the best context possible is just the best place to start.